Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Sailboat Petrochemical, also known as Sierbang Petrochemical, is a leading Chinese manufacturer of high-end new materials and fine chemicals. Based in Lianyungang, the company operates one of the world's largest methanol-to-olefins (MTO) complexes, producing critical chemical precursors such as acrylonitrile, methyl methacrylate (MMA), and ethylene-vinyl acetate (EVA). These materials are essential components in the healthcare supply chain, used extensively in the production of medical-grade nitrile gloves, surgical instruments, and pharmaceutical packaging. In 2021, the company was acquired by Eastern Shenghong in a major restructuring to enhance the group's vertical integration in the petrochemical sector. While primarily an industrial entity, its dominant market position in medical raw materials makes it a significant player in the broader healthcare ecosystem. The company continues to expand its portfolio into green chemicals and high-performance polymers to meet evolving global demands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Sailboat Petrochemical.